RRC ID 63197
著者 Park E, Kim J, Jin HS, Choi CW, Choi TH, Choi S, Huh D, Jeong SY.
タイトル Scopolin Attenuates Osteoporotic Bone Loss in Ovariectomized Mice.
ジャーナル Nutrients
Abstract Bone remodeling is a renewal process regulated by bone synthesis (osteoblasts) and bone destruction (osteoclasts). A previous study demonstrated that Lycii radicis cortex (LRC) extract inhibited ovariectomized (OVX)-induced bone loss in mice. This study investigated the anti-osteoporotic effects of bioactive constituent(s) from the LRC extract. The effective compound(s) were screened, and a single compound, scopolin, which acts as a phytoalexin, was chosen as a candidate component. Scopolin treatment enhanced alkaline phosphatase activity and increased mineralized nodule formation in MC3T3-E1 pre-osteoblastic cells. However, osteoclast differentiation in primary-cultured monocytes was reduced by treatment with scopolin. Consistently, scopolin treatment increased osteoblast differentiation in the co-culture of monocytes (osteoclasts) and MC3T3-E1 (osteoblast) cells. Scopolin treatment prevented bone mineral density loss in OVX-induced osteoporotic mice. These results suggest that scopolin could be a therapeutic bioactive constituent for the treatment and prevention of osteoporosis.
巻・号 12(11)
公開日 2020-11-20
DOI 10.3390/nu12113565
PII nu12113565
PMID 33233714
PMC PMC7699886
MeSH 3T3 Cells Animals Bone Density / drug effects Cell Differentiation Coumarins / pharmacology Coumarins / therapeutic use* Disease Models, Animal Drugs, Chinese Herbal / pharmacology Drugs, Chinese Herbal / therapeutic use* Female Glucosides / pharmacology Glucosides / therapeutic use* Mice Osteoblasts / drug effects Osteoclasts / drug effects Osteogenesis / drug effects* Osteoporosis / drug therapy* Osteoporosis / prevention & control*
IF 4.546
リソース情報
ヒト・動物細胞 MC3T3-E1(RCB1126)